Inderm Lotion (Erythromycin)

• Erythromycin lotion is a topical macrolide antibiotic used to manage bacterial skin conditions.
• Acne vulgaris: reduces inflammatory lesions and bacterial colonisation.
• Folliculitis: clears infection of hair follicles caused by susceptible bacteria.
• Other bacterial skin infections: treats localized infections such as impetigo caused by erythromycin‑sensitive organisms.

• Erythromycin binds to the 50S subunit of bacterial ribosomes, blocking the translocation step of protein synthesis. This inhibition is bacteriostatic, preventing bacterial growth and allowing the host immune system to eradicate the infection. The drug’s affinity for the ribosomal binding site confers activity against a range of Gram‑positive and some Gram‑negative organisms that are susceptible to macrolides.

Topical erythromycin may cause a range of skin‑related adverse reactions.

Common Side Effects

• Skin irritation: mild burning or stinging at the application site.
• Itching (pruritus): localized discomfort.
• Dryness or flaking of the skin.
• Redness (erythema) around the treated area.
• Contact dermatitis: allergic skin reaction.
• Peeling or scaling.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rapid swelling, difficulty breathing.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: extensive skin blistering.
• Photosensitivity: heightened skin reaction to sunlight.
• Drug eruption: widespread rash.
• Development of resistant bacterial strains with prolonged use.

• When using Inderm Lotion, consider the following safety measures.
• Assess for hypersensitivity: avoid use in patients with known erythromycin allergy.
• Limit duration: prolonged use may promote bacterial resistance.
• Avoid on extensive skin damage: do not apply to open wounds unless specifically directed.
• Use with caution in pregnancy: consult a healthcare professional before use.
• Avoid concurrent use with other topical antibiotics unless instructed.
• Store at room temperature: keep in the original container, protect from light and moisture.

Topical erythromycin can interact with other medications, primarily when systemic absorption is possible.

Major Interactions (Avoid)

• Concurrent systemic macrolide therapy: may increase risk of additive toxicity and promote resistance.
• Oral erythromycin: simultaneous use can lead to unnecessary duplication of therapy.

Moderate Interactions (Monitor Closely)

• Cytochrome P450 inhibitors (e.g., clarithromycin, ketoconazole): may raise systemic levels if large skin areas are treated.
• Other topical antibiotics: monitor for overlapping toxicity or resistance development.
• Antifungal agents applied to the same area: assess for potential irritation.